While only 2% are ready, most companies expect productivity gains of 10-40% with Enterprise AI: Infosys Research (1)
Prepare data infrastructure for AI: Data health is crucial for AI success but remains a challenge. Only 10% of the companies ...
Bluecrux Teams Up with Bridgestone for Seamless SAP S/4HANA Upgrade
Since the implementation of SAP S/4HANA, Bridgestone has been able to harmonize its processes across the organization. The platform is seen as a crucial enabler for future initiatives and projects as ...
SUSTAINABLE MARKETS INITIATIVE UNVEILS SUPPORT TO COMMONWEALTH MEMBER STATES AT CHOGM (2)
Marine Mangrove Sanctuary launched in partnership with SpaceX and Rotary International in Samoa to restore mangrove ...
Infosys Expands Strategic Collaboration with Meta: Unveils Center of Excellence to Drive Enterprise AI Innovation throug
Infosys (NSE: INFY), (BSE: INFY), (NYSE: INFY), a global leader in next-generation digital services and consulting, today ...
eM Client Acquires Postbox Inc., Expanding Its Reach to a Broader User Base
eM Client offers one-time purchase and subscription-based licensing models, making it an ideal solution for individuals and ...
Infosys: Strong performance with broad based revenue growth in CC of 3.1% sequentially and 3.3% YoY (1)
Margin guidance retained at 20%-22% BENGALURU, India, Oct. 17, 2024 /PRNewswire/ -- Infosys (NSE: INFY) (BSE: INFY) (NYSE: ...
Election integrity at stake: Report highlights governance issues in the US
Voter turnout, a crucial metric of engagement, lags behind other advanced democracies, raising concerns about public ...
Chiesi launches innovation platform focused on partnership and patient care: The Impulse
Chiesi Group, a research-oriented international biopharmaceutical group, is proud to announce the official launch of The Impulse, an innovation platform designed to accelerate bold ideas and ...
First participants enrolled in first-in-human Phase I clinical trial with nociceptin (NOP) receptor agonist
Today, Grünenthal announced that the first participants have been enrolled in a first-in-human Phase I clinical trial for a nociceptin (NOP) receptor agonist. The trial will include 90 healthy ...
Notimerica7d
PIONIERKRAFT recauda una alta cantidad de siete cifras en la ronda de financiación Serie A
Munich-based energy start-up PIONIERKRAFT has raised a high seven-figure amount in its Series A financing round, led by First ...
Notimerica14d
Epitomee Medical to Present the Epitomee Breakthrough Oral Delivery Platform at PODD 2024 Conference
The Epitomee Platform enables oral delivery of significant amounts of large molecules, including proteins and peptides. The platform dramatically boosts bioavailability, offering game-changing ...